Tianjin Medical University General Hospital

This study tests whether the drug tocilizumab can safely prevent relapses in people with MOGAD, a rare autoimmune disease that attacks the nervous system. About 102 participants aged 12 and older with recent relapses will receive either tocilizumab or a placebo. The main goal is …

This study aimed to test the drug eculizumab for treating sudden attacks of neuromyelitis optica spectrum disorder (NMOSD) in adults who test positive for a specific antibody. The goal was to see if the drug could quickly reduce disability by blocking harmful immune system activi…